The University of Chicago Header Logo

Connection

S. Margaret Paik to Postmenopause

Back to Details
This is a "connection" page, showing publications S. Margaret Paik has written about Postmenopause.
S. Margaret Paik
Connection Strength
0.035
Postmenopause
  1. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2019 01; 20(1):88-99.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.